Sands Capital Ventures Discovery Fund III, L.P.

Insider Reports History

Location
Arlington, VA
Signature
/s/ Jonathan Goodman, General Counsel of Sands Capital Ventures Discovery Fund III-GP, LLC, the General Partner of Sands Capital Ventures Discovery Fund III, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sands Capital Ventures Discovery Fund III, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 3,417,075 $11,859,300 $3.47 06 Jul 2021 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Jul 2021 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 06 Jul 2021 Direct

Insider Reports Filed by Sands Capital Ventures Discovery Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 5 +$6,696,000 4 10%+ Owner 08 Jul 2021, 17:21
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 10%+ Owner 30 Jun 2021, 20:10